Added to YB: 2019-07-29
Pitch date: 2019-07-29
MRNS:US [bullish]
Marinus Pharmaceuticals, Inc.
-88.04%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure disorders.
Market Cap
$30.4M
Pitch Price
$4.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.71
P/E
-0.22
EV/Sales
2.65
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Marinus Pharmaceuticals Inc MRNS:US
A summary for this pitch has not been created yet.
Read full article (0 min)